The comparative efficacy and safety of herpes zoster vaccines: A network meta-analysis.
CONCLUSION: RZV is significantly more effective in reducing HZ and PHN incidence in adults ≥60 YOA, compared with ZVL. As anticipated with an adjuvanted vaccine, RZV results in more reactogenicity following immunization. No differences in SAEs were found between RZV and ZVL.
PMID: 30982636 [PubMed - as supplied by publisher]
Source: Vaccine - Category: Allergy & Immunology Authors: McGirr A, Widenmaier R, Curran D, Espié E, Mrkvan T, Oostvogels L, Simone B, McElhaney JE, Burnett H, Haeussler K, Thano A, Wang X, Newson RS Tags: Vaccine Source Type: research
More News: Allergy & Immunology | Herpes | Shingles (Herpes Zoster) Vaccine | Statistics | Study | Vaccines | Varicella-Zoster Virus Vaccine